Patent Number: 7,132,396

Title: Compositions which can be used for regulating the activity of parkin

Abstract: The present invention relates to novel compounds and their uses, in particular their pharmaceutical or diagnostic uses or their use as pharmacological targets. More particularly, the present invention relates to a novel protein, referred to as PAP1, as well as to novel peptides and compounds which are capable of modulating, at least partially, the activity of parkin.

Inventors: Koutnikova; Hana (Ostwald, FR), Brice; Alexis (Paris, FR), Fournier; Alain (Chatenay Malabry, FR), Pradier; Laurent (Verrieres, FR), Prades; Catherine (Thiais, FR), Arnould-Reguigne; Isabelle (Chennevieres sur Marne, FR), Rosier-Montus; Marie-Francoise (Antony, FR), Corti; Olga (Paris, FR)

Assignee: Aventis Pharma S.A.

International Classification: A61K 38/17 (20060101); C07K 14/435 (20060101)

Expiration Date: 2019-11-07 0:00:00